| Heterogeneity of the MYCN oncogene in neuroblastoma. | neuroblastoma, |
| Expression of c-myc proto-oncogene during podophyllotoxin induced IW32 erythroleukemia cell differentiation. | leukemia, |
| All-trans retinoic acid induces Thrombospondin-1 expression in acute promyelocytic leukemia cells though down-regulation of its transcription repressor, c-MYC oncoprotein. | leukemia, |
| Alveolar macrophages stimulated with SiO(2) have the ability to induce c-myc oncogene expression in human embryo lung fibroblasts. | lung, |
| [Effect of silicosis alveolar macrophages on expression of c-myc in human embryo lung fibroblast in vitro]. | lung, |
| The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. | neuroblastoma, |
| Expression of the c-myc oncogene and the presence of HPV 18: possible surrogate markers for cervical cancer?. | cervical, |
| Loss of heterozygosity of the L-myc oncogene in human breast tumors. | breast, |
| Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients. | neuroblastoma, |
| Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells. | lung, |
| Neuroblastoma and the clinical significance of N-myc oncogene amplification. | neuroblastoma, |
| Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues. | thyroid, |
| [Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma]. | neuroblastoma, |
| N-myc oncogene expression in porcine renal development and oncogenesis. | kidney, |
| The oncogene c-myc is overexpressed in human laryngeal cancer tissues, and may play an important role in carcinogenesis and progression. | laryngeal, |
| [The expression of oncogene c-myc and its role on human laryngeal cancer]. | laryngeal, |
| 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. | colorectal,breast,prostate, |
| we describe an interesting oncogenic mechanism in chronic lymphocytic leukemia patients resistant to fludarabine by which the complete MYC-specific regulatory network was altered | leukemia, |
| Genomic rearrangement of the c-myc proto-oncogene in non-AIDS-related lymphoma in Japan. | lymphoma, |
| Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis. | leukemia, |